Impact Biomedical Inc. Files Q1 2025 10-Q
Ticker: IBO · Form: 10-Q · Filed: May 14, 2025 · CIK: 1834105
| Field | Detail |
|---|---|
| Company | Impact Biomedical Inc. (IBO) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
IMPACT BIOMEDICAL INC. FILED ITS Q1 2025 10-Q. CHECK FINANCIALS.
AI Summary
Impact Biomedical Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, incorporated in Nevada, operates in the pharmaceutical preparations sector. Its principal business address is located in Houston, Texas.
Why It Matters
This filing provides investors with an update on Impact Biomedical Inc.'s financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant financial events indicated in the provided header information.
Key Numbers
- 20250331 — Reporting Period End Date (Quarterly report covers the period ending March 31, 2025.)
- 20250514 — Filing Date (The 10-Q was filed on May 14, 2025.)
Key Players & Entities
- IMPACT BIOMEDICAL INC. (company) — Filer
- 0001834105 (company) — Central Index Key
- 2834 (dollar_amount) — Standard Industrial Classification (Pharmaceutical Preparations)
- NV (company) — State of Incorporation
- 1231 (dollar_amount) — Fiscal Year End
- 001-42212 (dollar_amount) — SEC File Number
- 25945741 (dollar_amount) — Film Number
- 1400 BROADFIELD BLVD. SUITE 130 (dollar_amount) — Business Address
- HOUSTON (company) — City
- TX (company) — State
FAQ
What is the company's primary business activity?
Impact Biomedical Inc. operates in the Pharmaceutical Preparations sector, as indicated by SIC code 2834.
When was this quarterly report filed?
This 10-Q filing was made on May 14, 2025.
For which fiscal period is this report?
The report covers the first quarter of the fiscal year, ending on March 31, 2025.
Where is Impact Biomedical Inc. headquartered?
The company's business address is listed as 1400 Broadfield Blvd., Suite 130, Houston, TX 77084.
What is the company's state of incorporation?
Impact Biomedical Inc. is incorporated in Nevada (NV).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding IMPACT BIOMEDICAL INC. (IBO).